Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis

Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis

In patients suffering from multiple sclerosis (MS), intrathecal injection of triamcinolone acetonide (TCA) has been shown to improve symptoms of spasticity. Although repeated intrathecal injection of TCA has been used in a number of studies in late-stage MS patients with spinal cord involvement, no...

Full description

Bibliographic Details
Main Authors: Andreas Hoeflich, Brit Fitzner, Christina Walz, Michael Hecker, Armin Tuchscherer, Manuela Bastian, Julia Brenmoehl, Ina Schröder, Holger S. Willenberg, Martin Reincke, Uwe Klaus Zettl
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Endocrinology
Subjects:
multiple sclerosis
intrathecal administration
cortisol
systemic effects
blood brain-barrier
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2020.00574/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2020.00574/full

Similar Items